It takes two to tango! Stability of drugs affecting efficacy against Mycobacterium abscessus.
作者信息
Singh Sanjay, Srivastava Shashikant
机构信息
Department of Medicine, School of Medicine, University of Texas at Tyler, Tyler, Texas, USA.
Department of Medicine, School of Medicine, University of Texas at Tyler, Tyler, Texas, USA; Department of Cellular and Molecular Biology, University of Texas Health Science Center at Tyler, Tyler, Texas, USA.
出版信息
Int J Antimicrob Agents. 2024 Feb;63(2):107060. doi: 10.1016/j.ijantimicag.2023.107060. Epub 2023 Dec 12.
Abstract
摘要
相似文献
1
It takes two to tango! Stability of drugs affecting efficacy against Mycobacterium abscessus.一个巴掌拍不响！影响抗脓肿分枝杆菌疗效的药物稳定性。
Int J Antimicrob Agents. 2024 Feb;63(2):107060. doi: 10.1016/j.ijantimicag.2023.107060. Epub 2023 Dec 12.
2
Cyclohexyl-griselimycin Is Active against Mycobacterium abscessus in Mice.环己基格雷西霉素对小鼠中的脓肿分枝杆菌具有活性。
Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0140021. doi: 10.1128/AAC.01400-21. Epub 2021 Nov 1.
3
Bedaquiline and Clofazimine Susceptibility Testing in Mycobacterium abscessus.分枝杆菌属脓肿病中贝达喹啉和氯法齐明药敏试验
Antimicrob Agents Chemother. 2022 May 17;66(5):e0234621. doi: 10.1128/aac.02346-21. Epub 2022 Apr 14.
4
The aminoglycoside-modifying enzyme Eis2 represents a new potential target for reducing antimicrobial drug resistance in complex.氨基糖苷修饰酶Eis2是降低复杂抗菌药物耐药性的一个新的潜在靶点。
Eur Respir J. 2022 Dec 1;60(6). doi: 10.1183/13993003.01541-2022. Print 2022 Dec.
5
Improved Performance Predicting Clarithromycin Resistance in on an Independent Data Set.在独立数据集上预测克拉霉素耐药性的性能改进
Antimicrob Agents Chemother. 2019 Jul 25;63(8). doi: 10.1128/AAC.00400-19. Print 2019 Aug.
6
Indole-2-Carboxamides Are Active against in a Mouse Model of Acute Infection.吲哚-2-羧酰胺类化合物在急性感染的小鼠模型中具有活性。
Antimicrob Agents Chemother. 2019 Feb 26;63(3). doi: 10.1128/AAC.02245-18. Print 2019 Mar.
7
Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus In Vitro and in Macrophages.维拉帕米可提高贝达喹啉对脓肿分枝杆菌的体外和巨噬细胞内活性。
Antimicrob Agents Chemother. 2019 Aug 23;63(9). doi: 10.1128/AAC.00705-19. Print 2019 Sep.
8
Outcomes of Short-Term Tigecycline-Containing Regimens for Mycobacterium abscessus Pulmonary Disease.短期含替加环素方案治疗脓肿分枝杆菌肺病的结果。
Antimicrob Agents Chemother. 2022 Oct 18;66(10):e0077422. doi: 10.1128/aac.00774-22. Epub 2022 Sep 27.
9
Activity of Oral Tebipenem-Avibactam in a Mouse Model of Mycobacterium abscessus Lung Infection.口腔替比培南-阿维巴坦在鼠分枝杆菌肺感染模型中的活性。
Antimicrob Agents Chemother. 2023 Feb 16;67(2):e0145922. doi: 10.1128/aac.01459-22. Epub 2023 Jan 23.
10
A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium abscessus Activity .一种新型噁唑烷酮类药物，康替唑（MRX-I），对脓肿分枝杆菌表现出抗活性。
Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0088921. doi: 10.1128/AAC.00889-21. Epub 2021 Aug 30.
本文引用的文献
1
In vitro susceptibility testing of imipenem-relebactam and tedizolid against 102 Mycobacterium abscessus isolates.体外研究亚胺培南-雷巴他定和替加环素对 102 株脓肿分枝杆菌分离株的药敏试验。
Int J Antimicrob Agents. 2023 Oct;62(4):106938. doi: 10.1016/j.ijantimicag.2023.106938. Epub 2023 Jul 28.
2
Challenges and a potential solution to perform drug susceptibility testing of omadacycline against nontuberculous mycobacteria.检测奥马环素对非结核分枝杆菌的药敏试验所面临的挑战及潜在解决方案。
Tuberculosis (Edinb). 2022 Dec;137:102269. doi: 10.1016/j.tube.2022.102269. Epub 2022 Oct 4.
3
In vitro effects of diazabicyclooctane β-lactamase inhibitors relebactam and nacubactam against three subspecies of Mycobacterium abscessus complex.二氮杂双环辛烷β-内酰胺酶抑制剂瑞来巴坦和那库巴坦对脓肿分枝杆菌复合群三个亚种的体外作用
Int J Antimicrob Agents. 2022 Nov-Dec;60(5-6):106669. doi: 10.1016/j.ijantimicag.2022.106669. Epub 2022 Sep 3.
4
Insights into the l,d-Transpeptidases and d,d-Carboxypeptidase of Mycobacterium abscessus: Ceftaroline, Imipenem, and Novel Diazabicyclooctane Inhibitors.脓肿分枝杆菌 l,d-转肽酶和 d,d-羧肽酶的研究进展：头孢洛林、亚胺培南和新型二氮杂二环辛烷抑制剂。
Antimicrob Agents Chemother. 2020 Jul 22;64(8). doi: 10.1128/AAC.00098-20.
5
Activity of the New β-Lactamase Inhibitors Relebactam and Vaborbactam in Combination with β-Lactams against Mycobacterium abscessus Complex Clinical Isolates.新型β-内酰胺酶抑制剂雷利巴坦和沃巴坦与β-内酰胺类药物联合对脓肿分枝杆菌复合体临床分离株的活性。
Antimicrob Agents Chemother. 2019 Feb 26;63(3). doi: 10.1128/AAC.02623-18. Print 2019 Mar.
6
MIC-based dose adjustment: facts and fables.基于 MIC 的剂量调整：事实与虚构。
J Antimicrob Chemother. 2018 Mar 1;73(3):564-568. doi: 10.1093/jac/dkx427.
7
Susceptibility Testing of Antibiotics That Degrade Faster than the Doubling Time of Slow-Growing Mycobacteria: Ertapenem Sterilizing Effect versus Mycobacterium tuberculosis.降解速度快于生长缓慢的分枝杆菌倍增时间的抗生素的药敏试验：厄他培南的杀菌效果与结核分枝杆菌
Antimicrob Agents Chemother. 2016 Apr 22;60(5):3193-5. doi: 10.1128/AAC.02924-15. Print 2016 May.
8
In vitro activity of meropenem and imipenem against mycobacteria: development of a daily antibiotic dosing schedule.
Tuber Lung Dis. 1992 Jun;73(3):134-6. doi: 10.1016/0962-8479(92)90145-A.
Zotero 插件